Nick Pizzie, Chief Financial Officer at Axsome Therapeutics, Inc. (AXSM), sold 27,000 shares at $131.07 ($3.5M) on 2025-02-14, disclosed to the SEC on 2025-02-14.
Scheduled sale ($3.5M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $129.86 | 12,000 | $1.6M | 44.4% |
| 2 | $129.86 | 12,000 | $1.6M | 44.4% |
| 3 | $131.07 | 3,000 | $393K | 11.2% |
| Total | $129.99 avg | 27,000 | $3.5M | 100% |
| Filing → |
| AXSM | BUY | 2021-11-22 | $34K | — | Filing → |
| AXSM | BUY | 2020-06-30 | $119K | — | Filing → |
| AXSM | BUY | 2019-09-30 | $54K | — | Filing → |